2013 American Transplant Congress
Effect of Donor Right Hepatectomy on Regeneration of the Liver and the Spleen
Surgery, Seoul St Mary's Hospital, Catholic University of Korea, Seoul, Republic of Korea
Purpose: Donor hepatectomy for living donor liver transplantation accompanies physiomorphological changes of the liver and the spleen. Therefore, the long-term consequences of these organs should…2013 American Transplant Congress
Prospective Surveillance of Kidney Transplant Recipients for BK Viremia Can Reduce or Eliminate BK Virus Associated Nephropathy (BKVAN) Related Graft Loss: Results of a 5-Year Screening Study
Purpose: We aimed to identify the incidence and risk factors for BKVAN as well as measure the impact of immediate therapy on the graft and…2013 American Transplant Congress
Effect of Sirtuin 1 Gene Expression on Mouse Islet Graft Survival, The
Purpose: Islet transplantation is a promising therapy for Type 1 diabetes, however clinical application has not been as successful as organ transplantation due to early…2013 American Transplant Congress
Efficacy and Safety of Corticosteroid Withdrawal (CSW) in Kidney Transplant Recipients during Routine Practice: A Prospective, 4-Year Analysis from the Mycophenolic Acid Observational Renal Transplant (MORE) Study
Prospective, long-term data on efficacy and safety outcomes following CSW versus corticosteroid continuation (CSC) in kidney transplant patients during routine clinical practice are largely unavailable.Methods:…2013 American Transplant Congress
Efficacy and Safety of 3 vs. 6 Months of Low-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Moderate-Risk (D+/R+) Renal Transplant Recipients Receiving Antilymphocyte Antibody Induction Therapy
Multicenter CMV Pharmacists Collaborative Study Group, Boston
The cytomegalovirus (CMV) donor-positive/recipient-positive (D+/R+) population represents the largest group of at-risk renal transplant recipients (RTR). Practice guidelines on the prevention of CMV recommend prophylaxis…2013 American Transplant Congress
Intracoronary Treatment with VEGF-C/D Inhibitor Enhances Cardiac Allograft Survival and Prevents Chronic Rejection by Regulating Lymphatic Endothelial Cell Activation
Purpose: VEGF-C/D/VEGFR-3 signaling may regulate lymphatic vessel activation and the initiation of alloimmunity after transplantation. However, the mechanisms remain unknown. We investigated the effect of…2013 American Transplant Congress
Distinct Roles of CD137 and CD137L Bidirectional Signals in Candida albicans Infection
Invasive fungal infections by Candida albicans frequently cause mortality in immunocompromised patients, yet the cellular processes leading to this mortality remain ill-defined. Here, using genetic…2013 American Transplant Congress
Death on Wating-List and Risk of Transmission of Cancer: Where Is the Right Balance?
Cancer transmission from organ donors is a rare complication of transplantation. While some cancer histories in donors are classed as unacceptable or high risk because…2013 American Transplant Congress
Effect of Plasmapheresis on Angiotensin II Type I Receptor Antibody
The presence of angiotensin II type I receptor (AT1R) antibody has been associated with renal allograft rejection. We determined the presence of AT1R antibody in…2013 American Transplant Congress
Low-Dose Cyclosporine (CsA) Plus Mycophenolate Mofetil (MMF) and Prednisolone (Pred) Triple Immunosuppressive Protocol in Renal Transplantation
BACKGROUND: In order to decrease the rate of adverse effects of cyclosporin, a low-dose CsA plus MMF and Pred triple immunosuppressive protocol was started from…
- « Previous Page
- 1
- …
- 40
- 41
- 42
- 43
- 44
- …
- 178
- Next Page »